Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Implementing Long-Acting Cabotegravir + Rilpivirine in Arkansas Programs Utilizing Out-patient Clinics Versus In-home Visits

NCT05096949 is registered in ClinicalTrials.gov with University of Arkansas as lead sponsor.

NCT NCT05096949
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05096949 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Implementing Long-Acting Cabotegravir + Rilpivirine in Arkansas Programs Utilizing Out-patient Clinics Versus In-home Visits
Lead sponsor
University of Arkansas
Phase
Not applicable
Overall status
Terminated
Start date
March 7, 2022
Completion date
December 31, 2023
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv-1-infection, medication adherence, satisfaction, patient